UNSPSC 51241529: Glycerin/naphazoline

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OP800. This VA Drug Class (OP800) classifies this compound as belonging to the group DECONGESTANTS, TOPICAL OPHTHALMIC.

UNSPSC 51241529 Glycerin/naphazoline is a Commodity code under which state and local governments procure ophthalmic and nasal decongestant products as part of broader pharmaceutical supply agreements. State and local entities—primarily state health and procurement agencies—source these items alongside other generic pharmaceuticals and over-the-counter products through cooperative purchasing vehicles and multi-award contracts that establish pricing and supply relationships with authorized wholesalers. The products are distributed across state and local government facilities including clinics, correctional systems, and administrative health operations. Vendors supplying under this code must comply with cGMP and FDA requirements, maintain proper product documentation (NDC codes, SKUs, UPCs, strength, dosage form, and packaging configuration), hold contractual relationships with authorized drug wholesalers, and demonstrate pricing flexibility through flat-price, net-price, or WAC-minus structures.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP in January 2026 for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026. The RFP sought manufacturers to supply comprehensive product portfolios—including items within the glycerin/naphazoline family—to participating state and local facilities across Minnesota and Oregon through three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC). Awards are to be made on a sole, dual, or multi-award basis, with contracts effective July 1, 2026 for two years with optional extensions. Vendors must carry commercial general liability of $5 million per occurrence and network security liability of $2 million, and all products must have expiration dates of at least one year from manufacture with a six-month minimum shelf life. The evaluation weighted price competitiveness most heavily (75 percent), with the remainder split among fixed pricing (10 percent), administrative compliance (5 percent), EDI capability (5 percent), and agreement to a 3 percent administrative fee (5 percent).